PD-L1 anticorps (AA 39-191)
Aperçu rapide pour PD-L1 anticorps (AA 39-191) (ABIN6936651)
Antigène
Voir toutes PD-L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 39-191
-
Specificité
- PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.
-
Réactivité croisée (Details)
- Human.
-
Purification
- 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
-
Immunogène
- Recombinant fragment of human CD274 protein (around aa39-191) (exact sequence is proprietary)
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
-
Known_Application: ELISA (For coating, order antibody without BSA), ,Optimal dilution for a specific application should be determined.
Positive_Control: Heart, Placenta, Spleen or Tonsil.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS, WITHOUT BSA and Azide.
-
Agent conservateur
- Azide free
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
-
Date de péremption
- 24 months
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- CD274
-
Sujet
-
B7 homolog 1, B7-H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1,PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)
Cellular localisation: Cell Surface and Cytoplasmic -
Poids moléculaire
- 37-50kDa
-
ID gène
- 29126, 521989
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-